iShares Biotechnology ETF (NASDAQ:IBB) Stake Lessened by Lauer Wealth LLC

Lauer Wealth LLC cut its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 85.6% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,870 shares of the financial services provider’s stock after selling 11,143 shares during the period. Lauer Wealth LLC’s holdings in iShares Biotechnology ETF were worth $269,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. Future Financial Wealth Managment LLC purchased a new position in iShares Biotechnology ETF during the first quarter valued at approximately $27,000. Bbjs Financial Advisors LLC bought a new stake in iShares Biotechnology ETF during the 2nd quarter valued at approximately $31,000. Pacifica Partners Inc. boosted its position in shares of iShares Biotechnology ETF by 118.2% in the first quarter. Pacifica Partners Inc. now owns 240 shares of the financial services provider’s stock valued at $33,000 after acquiring an additional 130 shares during the period. Crewe Advisors LLC grew its position in iShares Biotechnology ETF by 42.9% in the 4th quarter. Crewe Advisors LLC now owns 260 shares of the financial services provider’s stock worth $35,000 after purchasing an additional 78 shares during the last quarter. Finally, YHB Investment Advisors Inc. bought a new position in iShares Biotechnology ETF during the first quarter valued at about $37,000. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Trading Up 1.4 %

iShares Biotechnology ETF stock traded up $1.99 on Tuesday, hitting $143.55. The company’s stock had a trading volume of 940,450 shares, compared to its average volume of 1,604,637. The company has a fifty day moving average price of $140.73 and a 200-day moving average price of $136.60. iShares Biotechnology ETF has a one year low of $111.83 and a one year high of $150.17.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.